Microbot Medical Statistics
Total Valuation
MBOT has a market cap or net worth of $159.16 million. The enterprise value is $81.44 million.
Important Dates
The next estimated earnings date is Wednesday, May 13, 2026, after market close.
| Earnings Date | May 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
MBOT has 67.16 million shares outstanding. The number of shares has increased by 192.69% in one year.
| Current Share Class | 67.16M |
| Shares Outstanding | 67.16M |
| Shares Change (YoY) | +192.69% |
| Shares Change (QoQ) | +39.94% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 17.48% |
| Float | 67.16M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | 36.29 |
| PB Ratio | 2.05 |
| P/TBV Ratio | 2.05 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 23.33, with a Debt / Equity ratio of 0.01.
| Current Ratio | 23.33 |
| Quick Ratio | 23.04 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -32.42% and return on invested capital (ROIC) is -22.46%.
| Return on Equity (ROE) | -32.42% |
| Return on Assets (ROA) | -21.04% |
| Return on Invested Capital (ROIC) | -22.46% |
| Return on Capital Employed (ROCE) | -18.87% |
| Weighted Average Cost of Capital (WACC) | 10.72% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$657,100 |
| Employee Count | 20 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +56.95% in the last 52 weeks. The beta is 1.19, so MBOT's price volatility has been higher than the market average.
| Beta (5Y) | 1.19 |
| 52-Week Price Change | +56.95% |
| 50-Day Moving Average | 2.26 |
| 200-Day Moving Average | 2.57 |
| Relative Strength Index (RSI) | 46.41 |
| Average Volume (20 Days) | 1,679,354 |
Short Selling Information
The latest short interest is 7.60 million, so 11.32% of the outstanding shares have been sold short.
| Short Interest | 7.60M |
| Short Previous Month | 7.54M |
| Short % of Shares Out | 11.32% |
| Short % of Float | 11.32% |
| Short Ratio (days to cover) | 3.41 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -14.74M |
| Pretax Income | -13.14M |
| Net Income | -13.14M |
| EBITDA | -14.70M |
| EBIT | -14.74M |
| Earnings Per Share (EPS) | -$0.29 |
Full Income StatementBalance Sheet
The company has $78.59 million in cash and $865,000 in debt, with a net cash position of $77.73 million or $1.16 per share.
| Cash & Cash Equivalents | 78.59M |
| Total Debt | 865,000 |
| Net Cash | 77.73M |
| Net Cash Per Share | $1.16 |
| Equity (Book Value) | 77.55M |
| Book Value Per Share | 1.15 |
| Working Capital | 76.40M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$13.05 million and capital expenditures -$60,000, giving a free cash flow of -$13.11 million.
| Operating Cash Flow | -13.05M |
| Capital Expenditures | -60,000 |
| Depreciation & Amortization | 47,000 |
| Net Borrowing | n/a |
| Free Cash Flow | -13.11M |
| FCF Per Share | -$0.20 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
MBOT does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -192.69% |
| Shareholder Yield | -192.69% |
| Earnings Yield | -8.26% |
| FCF Yield | -8.23% |
Analyst Forecast
The average price target for MBOT is $7.50, which is 216.46% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $7.50 |
| Price Target Difference | 216.46% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on September 5, 2018. It was a reverse split with a ratio of 1:15.
| Last Split Date | Sep 5, 2018 |
| Split Type | Reverse |
| Split Ratio | 1:15 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |
